Farallon Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-750,000
| Closed | -$10.2M | – | 121 |
|
|
2020
Q2 | $10.2M | Sell |
750,000
-500,000
| -40% | -$6.79M | 0.08% | 101 |
|
|
2020
Q1 | $9.48M | Buy |
+1,250,000
| New | +$9.48M | 0.08% | 81 |
|
|
2018
Q1 | – | Sell |
-825,000
| Closed | -$12.3M | – | 86 |
|
|
2017
Q4 | $12.3M | Buy |
825,000
+95,000
| +13% | +$1.41M | 0.1% | 62 |
|
|
2017
Q3 | $14.4M | Hold |
730,000
| – | – | 0.13% | 62 |
|
|
2017
Q2 | $10.5M | Buy |
+730,000
| New | +$10.5M | 0.11% | 64 |
|